Key Decisions Approved by Board

A. Sale of Subsidiary Stakes

The Board of Directors at its meeting held on July 22, 2026 (commenced at 05:00 PM IST, concluded at 07:18 PM IST) approved the sale of 80% stakes in two subsidiaries to Advait Greenergy Private Limited, a material subsidiary of Advait Energy Transitions Limited:

1. Advait Battery Ecosystems Private Limited (ABEPL) - Sale of 8,000 equity shares of face value ₹10 each at price of ₹10 each, aggregating to ₹80,000

2. Advait Carbon Advisory & Renewables Assets Private Limited (ACARA) - Sale of 8,000 equity shares of face value ₹10 each at price of ₹10 each, aggregating to ₹80,000

B. ESOP Grant Approval

The Board approved 7,376 grants under Advait Employee Stock Option Plan 2022 (ESOP 2022).

Detailed Subsidiary Sale Information

Financial Impact of Subsidiary Sales

  • Total consideration: ₹160,000 (₹80,000 from each subsidiary)
  • ABEPL incorporation date: April 27, 2026
  • ACARA incorporation date: April 20, 2026
  • Net worth of each subsidiary: ₹100,000
  • Turnover/Revenue/Income: NIL for both subsidiaries (newly incorporated)

Transaction Details

  • Buyer: Advait Greenergy Private Limited (subsidiary of Advait Energy Transitions Limited)
  • Expected completion date: September 15, 2026
  • Related party transaction: Yes
  • Arm's length basis: Yes
  • Scheme of Arrangement: Not applicable
  • Slump sale: Not applicable

Post-Transaction Structure

Following the sale, Advait Battery Ecosystems Private Limited and Advait Carbon Advisory & Renewables Assets Private Limited will become step-down subsidiaries of Advait Energy Transitions Limited.

ESOP Grant Details

General Terms and Conditions

  • Scheme compliance: In terms of SEBI (SBEB) Regulations, 2021
  • Total options granted: 7,376
  • Pricing formula: ₹10 per share (face value of the share)
  • Options vested: 7,376 options
  • Exercise period: 1 or 3 years from date of last vesting of options
  • Options exercised: 7,376 options
  • Money realized by exercise: ₹73,760
  • Total shares arising: 7,376 equity shares (each option convertible into 1 equity share of face value ₹10 each)
  • Options lapsed: 3,097 options
  • Variation of terms: No variation
  • Lock-in period: No lock-in period under the Plan
  • Subsequent changes: Non-vested options still have one year to exercise
  • Diluted EPS: ₹42.34 per share